Mundipharma   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Limburg Germany (1967)

Organization Overview

First Clinical Trial
2001
NCT01423032
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CHG Pontoise / SAMU 95 | Department Head, Clinical Trial Operations, Clinical Development, Mundipharma K.K. | Mundipharma AB | Mundipharma, China | Mundipharma China Ltd. | Mundipharma (China) Pharmaceutical Co. Ltd | Mundipharma CVA | Mundipharma Distribution GmBH (Philippine Branch) | Mundipharma-EDO GmbH | Mundipharma Finland | Mundipharma (Hong Kong) Ltd | Mundipharma K.K. | Mundipharma Korea Ltd | Mundipharma Manufacturing Pte Ltd. | Mundipharma Medical Company | Mundipharma Oy | Mundipharma Pharmaceuticals B.V. | Mundipharma Pharmaceuticals Sdn. Bhd. | Mundipharma Pharmaceuticals S.L. | Mundipharma Pharmaceuticals srl | Mundipharma Pte Ltd. | Mundipharma Research GmbH & Co KG | Mundipharma Research Limited | Mundipharma Research Ltd | Mundipharma SAS | Norpharma A/S | Norpharma A/S, Slotsmarken 15, DK-2970 Hoersholm, Denmark | Taiwan Mundipharma Pharmaceuticals Ltd.

Active Ingredients

Drugs in Phase 4 Trials (16)

acetaminophen (tylenol) (2 trials)

buprenorphine (20 trials)

chlorhexidine (hibitane) (2 trials)

fluticasone (cutivate) (17 trials)

formoterol (foradil) (17 trials)

mannitol (Osmitrol) (1 trial)

methoxyflurane (penthrane) (3 trials)

morphine (9 trials)

naloxone (narcan) (27 trials)

oxycodone (oxycontin) (38 trials)

povidone-iodine (betadine) (3 trials)

pralatrexate (folotyn) (3 trials)

prednisone (meticorten) (5 trials)

salmeterol (serevent) (2 trials)

sodium chloride (3 trials)

tramadol (Ultram) (6 trials)

Drugs in Phase 3 Trials (16)

bendamustine (treanda) (20 trials)

budesonide (rhinocort) (1 trial)

celecoxib (celebrex) (1 trial)

cobalamin (1 trial)

cyclophosphamide (cytoxan) (3 trials)

fludarabine (fludara) (2 trials)

folic acid (2 trials)

glycopyrronium (robinul) (1 trial)

hydromorphone (diladid) (1 trial)

indacaterol (arcapta neohaler) (1 trial)

ketoprofen (orudis) (1 trial)

lidocaine (xylocaine) (1 trial)

methadone (methadose) (1 trial)

obinutuzumab (gazyva) (1 trial)

rituximab (rituxan) (9 trials)

vilanterol (Anoro Elipta) (1 trial)

Drugs in Phase 2 Trials (18)

autologous mononuclear stem cell (1 trial)

beclomethasone (vanceril) (1 trial)

bortezomib (velcade) (4 trials)

cyanocobalamin (berocca) (1 trial)

cytarabine (cytosar-u) (3 trials)

etoposide (vepesid) (1 trial)

forodesine (4 trials)

lenalidomide (revlimid) (3 trials)

melphalan (alkeran) (2 trials)

naltrexone (revia) (1 trial)

rezafungin (REZZAYO) (2 trials)

sulfamethoxazole (gantanol) (1 trial)

talaporfin (Laserphyrin) (1 trial)

temsirolimus (torisel) (2 trials)

thalidomide (Thalomid) (1 trial)

thiotepa (1 trial)

tinostamustine (6 trials)

urea (3 trials)

Drugs in Phase 1 Trials (5)

Key: Mundipharma (3) Acquired (2)

Filgrastim (neupogen) (2 trials)

lomustine (1 trial)

mr2xxx (2 trials)

Pegfilgrastim (1 trial)

pembrolizumab (keytruda) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Acute Pain (Phase 4)

Aggression (Phase 2)

Arthralgia (Phase 4)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 4)

Back Pain (Phase 4)

Cancer Pain (Phase 4)

Chronic Pain (Phase 4)

Constipation (Phase 4)

Cystitis (Phase 2)

Cystitis, Interstitial (Phase 2)

Diabetic Neuropathies (Phase 2)

Disease (Phase 4)

Disease Progression (Phase 4)

Emergencies (Phase 4)

Endometrial Neoplasms (Phase 2)

Giant Cell Arteritis (Phase 3)

Glioblastoma (Phase 1)

Gliosarcoma (Phase 1)

Herpes Zoster (Phase 3)

Hodgkin Disease (Phase 1)

Hyperplasia (Phase 2)

Inflammation (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Prolymphocytic (Phase 1)

Leukemia, Prolymphocytic, T-Cell (Phase 1)

Low Back Pain (Phase 4)

Lower Urinary Tract Symptoms (Phase 2)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lymphoma (Phase 4)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 1)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 4)

Lymphoma, T-Cell, Cutaneous (Phase 1)

Lymphoma, T-Cell, Peripheral (Phase 4)

Melanoma (Phase 1)

Meningeal Carcinomatosis (Phase 1)

Mucositis (Phase 2)

Multiple Myeloma (Phase 2)

Myalgia (Phase 4)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Osteoarthritis (Phase 4)

Ovarian Neoplasms (Phase 2)

Pain (Phase 2)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 3)

Peripheral Nervous System Diseases (Phase 4)

Polymyalgia Rheumatica (Phase 3)

Polyneuropathies (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prostatic Hyperplasia (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Sarcoma (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Spinal Cord Diseases (Phase 3)

Spinal Diseases (Phase 4)

Syndrome (Phase 2)

Tissue Adhesions (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 133
  • # of Trial APIs: 55